NOTICE TO THE BAR
RE: Application to Designate Remicade, Embral and Celebrex Litigation as a Mass Tort
Pursuant to Rule 4:38A and the Mass Tort Guidelines (Directive #11-03), an application has been submitted to the Supreme Court, through the Administrative Director of the Courts, to designate all litigation (pending and subsequently filed) involving the medications Remicade, Enbrel and Celebrex as a mass tort and assign it for centralized management to Atlantic County.
Anyone wishing to comment on or object to this application should provide such comments or objections, with relevant supporting documentation, to the Administrative Director of the Courts, P. O. Box 037, Trenton, NJ 08625-0037, by August 13, 2004.
Richard J. Williams
|Copyrighted © 2001 - New Jersey Judiciary|